Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1.

Wu J, Niu Q, Yuan J, Xu X, Cao L.

DOI: 10.3892/etm.2019.8080
Published: 2019-10-07
Container: Exp Ther Med
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3892/etm.2019.8080,
  title = {Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1.},
  author = {Wu J and  Niu Q and  Yuan J and  Xu X and  Cao L.},
  year = {2019},
  journal = {Exp Ther Med},
  doi = {10.3892/etm.2019.8080},
  url = {https://doi.org/10.3892/etm.2019.8080}
}

RIS

TY  - JOUR
TI  - Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1.
AU  - Wu J
AU  -  Niu Q
AU  -  Yuan J
AU  -  Xu X
AU  -  Cao L.
PY  - 2019
JO  - Exp Ther Med
DO  - 10.3892/etm.2019.8080
UR  - https://doi.org/10.3892/etm.2019.8080
ER  -

APA

J, W., Q, N., J, Y., X, X., & L., C. (2019). Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1.. Exp Ther Med. https://doi.org/10.3892/etm.2019.8080

Source records

europe-pmc · retrieved 2026-09-24T20:06:01.896Z